![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/23 | |
A61K 31/609 | |||
A61P 19/02 |
(11) | Number of the document | 1945243 |
(13) | Kind of document | T |
(96) | European patent application number | 06806679.4 |
Date of filing the European patent application | 2006-11-03 | |
(97) | Date of publication of the European application | 2008-07-23 |
(45) | Date of publication and mention of the grant of the patent | 2015-07-15 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2006/010576 |
Date | 2006-11-03 |
(87) | Number | WO 2007/051641 |
Date | 2007-05-10 |
(30) | Number | Date | Country code |
0522566 | 2005-11-04 | GB |
(72) |
AZRIA, Moise, CH
CHRISTIANSEN, Claus, DK
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
Nordic Bioscience A/S, Herlev Hovedgade 207, 2730 Herlev, DK |
(54) | USE OF CALCITONIN FOR THE TREATMENT OF RA |
USE OF CALCITONIN FOR THE TREATMENT OF RA |